Cogent Biosciences (COGT) Capital Expenditures (2017 - 2026)
Cogent Biosciences (COGT) posted Capital Expenditures of $370,000 for Q2 2026, up 182.4% from $131,000 a year earlier but down 17.6% from the prior quarter.
Powered by 
Analysis
Cogent Biosciences (COGT) Capital Expenditures (2017 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Capital Expenditures at Cogent Biosciences was $1.7 million, up 64.1% year-over-year; for FY2025, it was $1.55 million, up 171.2% from FY2024.
- Annual Capital Expenditures shows a four-year compound annual growth rate of -2.5% (FY2021 to FY2025).
- In prior years, Cogent Biosciences' Capital Expenditures was $573,000 in FY2024 (-79.5%), $2.8 million in FY2023 (-59.3%), $6.86 million in FY2022 (+299.2%) and $1.72 million in FY2021.
- Quarterly Capital Expenditures has run from a low of $65,000 in Q3 2025 to a high of $3.31 million in Q3 2022 over five years.
- On a year-over-year basis, Capital Expenditures increased in four of the last eight quarters, with growth averaging 224.3%.
- The strongest year-over-year quarter for Capital Expenditures in the past five years was Q4 2025, with growth of 981.3%; the weakest was Q3 2023, with a decline of 96.3%.
- According to Business Quant data, Capital Expenditures for the three prior quarters was $449,000 (Q1 2026), $811,000 (Q4 2025) and $65,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 1.36 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 533.00 Mn |
| 10 | Cogent Biosciences | 5.37 Bn | 2.42 Bn | - | 370,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 370,000.00 |
| Mar 31, 2026 | 449,000.00 |
| Dec 31, 2025 | 811,000.00 |
| Sep 30, 2025 | 65,000.00 |
| Jun 30, 2025 | 131,000.00 |
| Mar 31, 2025 | 547,000.00 |
| Dec 31, 2024 | 75,000.00 |
| Sep 30, 2024 | 280,000.00 |
| Jun 30, 2024 | 148,000.00 |
| Mar 31, 2024 | 70,000.00 |
| Dec 31, 2023 | 315,000.00 |
| Sep 30, 2023 | 121,000.00 |
| Jun 30, 2023 | 1.26 Mn |
| Mar 31, 2023 | 1.10 Mn |
| Dec 31, 2022 | 1.97 Mn |
| Sep 30, 2022 | 3.31 Mn |
| Jun 30, 2022 | 1.14 Mn |
| Mar 31, 2022 | 441,000.00 |
| Dec 31, 2021 | 433,000.00 |
| Sep 30, 2021 | 1.16 Mn |
API Access
Cogent Biosciences Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=COGT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "COGT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=COGT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();